Latest Breaking News On - தலை ஆஃப் தி துறை சிறுநீரகம் - Page 1 : comparemela.com
Международная неделя урологии: специалисты ДРБ призывают обращаться за помощью
gorod.lv - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from gorod.lv Daily Mail and Mail on Sunday newspapers.
Международная неделя урологии: специалисты ДРБ призывают обращаться за помощью - Медицина, красота
reitingi.lv - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from reitingi.lv Daily Mail and Mail on Sunday newspapers.
New Drug Combats Late-stage Prostate Cancer by Angela Mohan on July 12, 2021 at 11:18 AM
New treatment combats late stage prostate cancer by delivering beta radiation directly to tumour cells. It is well tolerated by patients and keeps them alive for longer compared to standard care, as per the phase 3 trial findings.
New approach, targets a molecule called PSMA, which is known to be increased on the surfaces of the tumour cells, destroying them and their surrounding microenvironment.
International team of researchers set out to see whether Lu-PSMA-617 was more effective than standard care and recruited 831 patients with metastatic castration-resistant prostate cancer between June 2018 and October 2019. Patients were randomized to receive the treatment plus standard care or standard care alone.
New Drug Targets Treatment-Resistant Prostate Cancers and Prolongs Trial Participants Lives
technologynetworks.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from technologynetworks.com Daily Mail and Mail on Sunday newspapers.
E-Mail
A new class of drug successfully targets treatment-resistant prostate cancers and prolongs the life of patients. The treatment delivers beta radiation directly to tumour cells, is well tolerated by patients and keeps them alive for longer than standard care, found a phase 3 trial to be presented at the European Association of Urology congress, EAU21, today.
Despite progress in medicine in recent years, metastatic castration-resistant prostate cancer remains untreatable and fatal. The new treatment, known as Lu-PSMA-617, takes a new approach, targeting a molecule called PSMA, which is known to be increased on the surfaces of the tumour cells, destroying them and their surrounding microenvironment.